menu
ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

AMARILLO BIOSCIENC (AMAR)
0.24 0 (0%)  12-15 10:41
Open: 0.24 Prev Close: 0.24
High: 0.24 Low: 0.24
Volume: 227 Market Cap: 6M
Year High: 5.8 Year Low: 0.03
Stock Technical Analysis
Overall       
Targets Six months: 4.2000    One year: 6.7744
Supports Support1: 0.0300   Support2: 0.0250
Resistances Resistance1: 3.5959    Resistance2: 5.8000 
Pivot Point 1.2805 
Moving Averages MA(5): 0.2138      MA(20): 1.5664 

MA(100): 2.0071  -1     MA(250): 2.2714 
MACD MACD(12,26): -0.422      Signal(12,26,9): -0.213 
Stochastic Oscillator %K(14,3): 3.871      %D(3): 3.580 
RSI RSI(14): 47.293 
52-Week High: 5.8000  Low: 0.0300  Change(%): 314
Average Volume(K) 3-Month: 371  10-Days: 3
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is below its mid-term; and below long term moving averages. From the relationship between price and moving averages; we can see that: this stock is BEARISH in short-term; and BEARISH in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed above bottom band by 38.5%; Bollinger Bands are 11.2% narrower than normal.The current width of the bands does not suggest anything about the future direction or movement of prices.

Stoxline

Stock Chart

Top 100 stocks

Stock News
Amarillo Biosciences Inc.
Mon, 18 Apr 2011 09:17:52 GMT

Amarillo Biosciences, Inc. Announces Investor Update
Wed, 06 Sep 2017 13:30:00 GMT

Amarillo Biosciences (AMAR) Issues Quarterly Earnings Results
Fri, 08 Dec 2017 01:52:30 GMT

Amarillo Biosciences (AMAR) Announces Earnings Results
Wed, 22 Nov 2017 13:52:00 GMT

Amarillo Biosciences Inc. (AMAR) Issues Earnings Results
Fri, 17 Nov 2017 15:58:10 GMT

Cellectar Biosciences Inc.
Mon, 24 Feb 2014 12:51:38 GMT

2016 Pipeline of Hepatitis C Market Covering 84 Companies
Thu, 19 May 2016 10:01:42 GMT

Respiratory Syncytial Virus (RSV) Infections Market Research Report H2: Drug ...
Wed, 22 Nov 2017 07:18:45 GMT

Respiratory Syncytial Virus {RSV} Infections Pharmaceutical and Healthcare ...
Wed, 15 Nov 2017 13:23:50 GMT

BioDelivery Sciences Appoints Thomas W. D'Alonzo to Board of Directors
Mon, 29 Apr 2013 11:02:53 GMT